ClinicalTrials.Veeva

Menu

Safety and Performance Study of the CyPass System Applier Model 241 (RePASS)

T

Transcend Medical

Status

Completed

Conditions

Open Angle Glaucoma (OAG)

Study type

Observational

Funder types

Industry

Identifiers

NCT02228577
TMI-14-01

Details and patient eligibility

About

This is a retrospective chart review of cases in which the CyPass Micro-Stent was implanted using the Model 241 Applier. The objective of this study is to characterize and evaluate the safety of the Model 241 Applier when used for CyPass Micro-Stent implantation.

Enrollment

172 patients

Sex

All

Ages

21+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  1. Diagnosis of OAG
  2. CyPass Micro-Stent implantation (using the CyPass system 241) following uncomplicated phacoemulsification cataract removal and intraocular lens implantation

Exclusion criteria

  1. Diagnosis of acute angle closure, traumatic, congenital, malignant, uveitic or neovascular glaucoma
  2. Prior incisional glaucoma surgery

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems